Some feel Pfizer's departure from Boulder might be less of a setback than it seems
Pfizer recently announced plans to shut down its Boulder operations. But the life sciences industry is seeing the biopharmaceutical giant’s departure as an opportunity. Chris Wood is Editor and Publisher of BizWest. He joined KUNC’s Nikole Robinson Carroll …